The Supreme Court may force Trump to take a position on mifepristone
CNN • • general
Key Points:
- The Trump administration has largely maintained a Biden-era regulatory framework that facilitates access to the abortion pill mifepristone, frustrating anti-abortion advocates who want stricter controls.
- A conservative 5th Circuit Court ruling requiring in-person doctor visits to obtain mifepristone threatens to limit nationwide access, challenging the administration's more cautious approach.
- The Supreme Court has temporarily paused the 5th Circuit ruling while considering the case, with the potential to hear it fully in the coming weeks, amid political and legal pressures.
- Anti-abortion groups criticize the Trump administration, particularly FDA head Marty Makary, for not acting decisively to restrict abortion pill access, fearing this may suppress Republican voter turnout.
- The administration appears to be balancing procedural legal defenses with reluctance to directly challenge the safety and approval of mifepristone, awaiting the Supreme Court's next move on the issue.
